As of 2025, retatrutide has not received a UK marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA), which is the licensing authority for Great Britain
Im always looking for the regulatory gaps and the trends where industry may be getting ahead of the science, so I certainly see some risks with claims being made in the GLP-1 dietary supplement space, said attorney Joseph Lyon, founding partner of The Lyon Firm
Whether you're battling chronic inflammation, rehabbing a post-surgical joint, or simply looking to keep your body in fighting shape, BPC-157 offers a non-hormonal, non-suppressive, multi-system tool for healing from the inside out
Nature medicine , 28(10), 20832091
When a prescriber adds tirzepatide to an existing HRT regimen, two questions surface immediately: will tirzepatide change how estradiol is absorbed, and does the combination increase cardiovascular or thrombotic risk